Lopez PD, Bhatia K, Bohra C, Mahmood K, et al. Benefits of Adding Glucagon-Like Peptide 1 Receptor Agonists to Sodium-Glucose
Co-Transporter 2 Inhibitors in Diabetic Patients With Atherosclerotic Disease and
Heart Failure. Am J Cardiol 2022 Aug 11. pii: S0002-9149(22)00750.
PMID: 35963825